Admittedly, future-gazing is a luxury in this industry and we rarely get it right. Further, most frequently, successful security is unappreciated, if not unnoticed. But the reality of medical device cybersecurity is that decisions made today are resulting in security debt that will have to be repaid in the future and has the potential to impact a manufacturer’s business in a significant way.
As you set security priorities for the next year and decade, ask yourself what if your organization has to face a future recall because of a security decision you made today - would that change the approach you are taking?
Ad Statistics
Times Displayed: 113248
Times Visited: 6741 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Regulators, security experts, and customers are all aligned around the objective of devices being designed for security and for the future. But has that been translated to a secure product development lifecycle? And if we’re not spending the money to design for the future today, we must, at a minimum, establish robust postmarket practices that include maintaining devices’ security posture and strategically choosing end-of-life products that no longer meet the required level of security.
About the author: Mike Kijewski is the CEO of MedCrypt. Mike is passionate about new advances in the intersection of internet technology and healthcare. Prior to starting MedCrypt, he was the founder of Gamma Basics, a radiation oncology-focused software startup. Gamma Basics was acquired by Varian Medical Systems in 2013.
Mike is a 2021 San Diego Business Journal Top 40 Under 40 and holds an MBA from the Wharton School, and a Master of Medical Physics from the University of Pennsylvania.
Back to HCB News
